It's been a good long minute since the phrase 'lightweight' and 'bike' have been paired together, but clearly 2023 is the year that it returns to the stage. Over the past decade or so the best road ...

If approved, Orca-T would be the first allogeneic T-cell immunotherapy for the treatment of hematological malignancies including acute myeloid leukemia, acute lymphoblastic leukemia and ...